1. Home
  2. OMDA vs EVO Comparison

OMDA vs EVO Comparison

Compare OMDA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMDA
  • EVO
  • Stock Information
  • Founded
  • OMDA 2011
  • EVO 1993
  • Country
  • OMDA United States
  • EVO Germany
  • Employees
  • OMDA N/A
  • EVO N/A
  • Industry
  • OMDA Medical/Nursing Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMDA Health Care
  • EVO Health Care
  • Exchange
  • OMDA Nasdaq
  • EVO Nasdaq
  • Market Cap
  • OMDA 1.2B
  • EVO 1.4B
  • IPO Year
  • OMDA 2025
  • EVO 2021
  • Fundamental
  • Price
  • OMDA $21.32
  • EVO $3.64
  • Analyst Decision
  • OMDA Strong Buy
  • EVO Buy
  • Analyst Count
  • OMDA 6
  • EVO 2
  • Target Price
  • OMDA $25.00
  • EVO $5.40
  • AVG Volume (30 Days)
  • OMDA 430.6K
  • EVO 50.2K
  • Earning Date
  • OMDA 08-07-2025
  • EVO 08-13-2025
  • Dividend Yield
  • OMDA N/A
  • EVO N/A
  • EPS Growth
  • OMDA N/A
  • EVO N/A
  • EPS
  • OMDA N/A
  • EVO N/A
  • Revenue
  • OMDA $209,827,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • OMDA $33.26
  • EVO $1.13
  • Revenue Next Year
  • OMDA $20.16
  • EVO $9.67
  • P/E Ratio
  • OMDA N/A
  • EVO N/A
  • Revenue Growth
  • OMDA 135.27
  • EVO N/A
  • 52 Week Low
  • OMDA $14.14
  • EVO $2.84
  • 52 Week High
  • OMDA $28.40
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • OMDA N/A
  • EVO 39.42
  • Support Level
  • OMDA N/A
  • EVO $3.50
  • Resistance Level
  • OMDA N/A
  • EVO $3.74
  • Average True Range (ATR)
  • OMDA 0.00
  • EVO 0.08
  • MACD
  • OMDA 0.00
  • EVO -0.02
  • Stochastic Oscillator
  • OMDA 0.00
  • EVO 29.17

About OMDA Omada Health Inc. Common Stock

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: